Investigating lung cancer risks in people with HIV-1 in Uganda and Tanzania
Characterization of the clinical epidemiology of lung cancer and relationship to HIV-1 infection in Uganda and Tanzania
This study is looking at how being infected with HIV-1 might increase the chances of getting lung cancer, especially in Uganda and Tanzania, and it wants to find out what other factors, like smoking and the environment, play a role so that we can come up with better ways to prevent and catch lung cancer early for people living with HIV-1.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10904978 on NIH RePORTER |
What this research studies
This research focuses on understanding how HIV-1 infection affects the risk of developing lung cancer, particularly in Uganda and Tanzania. It aims to identify various risk factors such as environmental influences, smoking habits, and geographical factors that may contribute to lung cancer in HIV-1 infected individuals. By gathering this information, the research seeks to create effective prevention strategies and screening programs tailored for those living with HIV-1, ultimately aiming to detect lung cancer earlier and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV-1 in Uganda and Tanzania, particularly those at risk for lung cancer.
Not a fit: Patients who do not have HIV-1 or those who are not at risk for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening and prevention strategies for lung cancer in HIV-1 infected individuals, potentially saving lives.
How similar studies have performed: Previous studies have indicated a link between HIV-1 infection and increased cancer risk, suggesting that this research builds on established findings rather than exploring entirely novel territory.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Kasasa, Simon — Case Western Reserve University
- Study coordinator: Kasasa, Simon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.